Found 9 matching trials
PI-88 in Hepatocellular Carcinoma After Hepatectomy
PHASE2The purpose of this study is to evaluate the efficacy of PI-88 to inhibit o...
Location
Kaohsiung Veterans General Hospital
Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
PHASE3The purpose of this study is to determine if PI-88 is effective and safe in...
Location
Multiple Locations
Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)
PHASE2PI-88 is a new experimental drug that inhibits tumour growth by reducing th...
Location
Sydney Cancer Centre, Royal Prince Alfred Hospital
Study of PI-88 in Patients With Advanced Melanoma
PHASE1The purpose of this study is to determine whether PI-88 is safe and effecti...
Location
University of Colorado Health Sciences Center
Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
PHASE2The aim of the study is to compare the safety and effectiveness of a new dr...
Location
Arizona Cancer Centre
PI-88 in Treating Patients With an Advanced Malignancy (Cancer) or Stage IV Melanoma
PHASE1RATIONALE: PI-88 may stop the growth of cancer by stopping blood flow to th...
Location
University of Colorado Cancer Center at University of Colorado Health Sciences Center
Docetaxel With or Without PI-88 in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
PHASE2RATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different...
Location
Sydney Heamatology and Oncology Clinics
Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer
PHASE2Docetaxel (Taxotere) is an approved chemotherapeutic drug for the treatment...
Location
Sydney Haematology and Oncology Clinics
A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection
PHASE3The purpose of this study is to determine if PI-88 is effective and safe in...
Location
The Third Xiangya Hospital of Central South University